Astria Therapeutics, Inc. (ATXS) Tops Q3 EPS by 16c; Reports Cash and Cash Equivalents of $131.8M

Go back to Astria Therapeutics, Inc. (ATXS) Tops Q3 EPS by 16c; Reports Cash and Cash Equivalents of $131.8M
(NASDAQ: ATXS) Delayed: 12.58 --0 (-0%)
Previous Close $12.58    52 Week High
Open $12.58    52 Week Low
Day High $12.58    P/E N/A 
Day Low $12.58    EPS
Volume 87,000